For the second quarter of the fiscal year ending March 2027, consolidated revenue was 179,970 million yen (Year-over-Year 3.8% increase), operating income was 19,439 million yen (Year-over-Year 87.3% increase), and interim profit was 13,313 million yen. The full-year earnings guidance was revised. By segment, Diabetes Management and Diagnostics & Life Sciences were robust, while Healthcare Solutions was a detractor to profit.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6523","jir_company_name":"PHC Holdings Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/6523-20261111-01.pdf","jir_short_summary":"For the second quarter of the fiscal year ending March 2027, consolidated revenue was 179,970 million yen (Year-over-Year 3.8% increase), operating income was 19,439 million yen (Year-over-Year 87.3% increase), and interim profit was 13,313 million yen. The full-year earnings guidance was revised. By segment, Diabetes Management and Diagnostics & Life Sciences were robust, while Healthcare Solutions was a detractor to profit.","jir_summary":"### Key Points of Results\nIn the second quarter of the fiscal year ending March 2027, PHC Holdings Corporation reported consolidated revenue of 179,970 million yen, a 3.8% increase year-over-year, and operating income of 19,439 million yen, a substantial improvement. By segment, Diabetes Management and Diagnostics & Life Sciences drove revenue and profit growth, while Healthcare Solutions experienced profit decline. The full-year earnings guidance was revised to reflect foreign exchange effects and anticipated cost reduction benefits.\n\n### Outlook and Impact\nThe revision to the full-year forecast reflects strong first-half performance while incorporating lower sales in Healthcare IT Solutions, resulting in divergent profit outlooks by segment. Attention should be paid to fluctuations in adjusted EBITDA that include foreign exchange impacts and one-time items related to M&A. This document does not include explicit statements on shareholder returns or capital policy.","jir_financial_highlights":"Revenue: 179,970 (Year-over-Year 3.8% increase)\nOperating Income: 19,439 (Year-over-Year over 80% increase)\nInterim Profit (Net Income Attributable to Owners of Parent): 13,313 (Previous year same period was -559)\nConsolidated Full-Year Forecast: Revised forecast (Revisions from initial full-year announcement)","jir_category":"","jir_hashtags":"#PHCHoldings, #Earnings, #BySegment","jir_key_figures":"Revenue: 179,970 million yen (Year-over-Year 3.8% increase)\nOperating Income: 19,439 million yen (Year-over-Year 87.3% increase)\nInterim Profit Attributable to Owners of Parent: 13,313 million yen","jir_meta_title":"PHC Holdings Corporation Second Quarter Financial Highlights and Full-Year Outlook | November 2026","jir_meta_description":"Summary of PHC Holdings Corporation's second quarter results for the fiscal year ending March 2027: trends in revenue and profit, segment performance, and revisions to the full-year outlook, including key metrics useful for investment decisions.","jir_og_title":"PHC Holdings Corporation Second Quarter Financial Highlights","jir_og_description":"A summary from PHC Holdings Corporation's financial summary highlighting second quarter revenue and profit trends and points of revision in the full-year forecast.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9274,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-149257","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n